Tissue factor pathway inhibitor‐γ is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans
- 17 July 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 6 (8), 1344-1351
- https://doi.org/10.1111/j.1538-7836.2008.03033.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in miceJournal of Thrombosis and Haemostasis, 2008
- Inhibition of tissue factor signaling suppresses tumor growthBlood, 2008
- Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue‐specific fibrin depositionJournal of Thrombosis and Haemostasis, 2007
- Sepsis-Induced Coagulation in the Baboon Lung Is Associated with Decreased Tissue Factor Pathway InhibitorThe American Journal of Pathology, 2007
- Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Human platelets synthesize and express functional tissue factorBlood, 2007
- Active tissue factor pathway inhibitor is expressed on the surface of coated plateletsBlood, 2006
- Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human plateletsThe Journal of Experimental Medicine, 2006
- Alternative splicing and RNA selection pressure — evolutionary consequences for eukaryotic genomesNature Reviews Genetics, 2006
- Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.The Journal of cell biology, 1989